Advertisement

CXA’s disruptive tech redefines global health insurance industry, starting with Asia

CXA’s platform uses a data-driven approach to design employee-tailored benefits and wellness programmes and to learn what works

Supported by:Discovery Reports
Reading Time:1 minute
Why you can trust SCMP
Rosaline Chow Koo, founder and CEO
Country Business Reports interviews and articles by Discovery Reports www.discoveryreports.com
Advertisement

One Singaporean technology company’s response to Asia’s rising health care costs is disrupting the health and benefits industry – winning for itself industry awards, the support of the Singaporean government and Fortune 500 clients.

Launched in 2014, CXA is already valued at US$100 million. Its recent series B funding was led by Facebook co-founder Eduardo Saverin and the investment arm of Singapore’s Economic Development Board.

“Chronic disease is hitting Asia hard, with a rapidly ageing population that is susceptible to diabetes at an even lower body mass index than most of the West,” says Rosaline Chow Koo, founder and CEO. “Our Asia-built solution is tailored to Asia’s needs. It empowers employees to stay healthy and helps employers optimise their benefits spending by shifting the focus from treatment to prevention.”

CXA’s platform uses a data-driven approach to design employee-tailored benefits and wellness programmes and to learn what works. With data, employers can actually quantify the return on their benefits and wellness investments, and drive down their insurance premiums. The platform consolidates information about employees through a lifestyle questionnaire and biometric health screening results from labs.

Advertisement

Employees get recommendations on how to become healthy, rewards for improvements and the opportunity to convert one-size-fits-all insurance spending to personalised benefits from the platform’s online shop – from yoga and diabetes management to individual insurance.

Advertisement